Status:
COMPLETED
Acute Intermittent Hypoxia in Persons With Multiple Sclerosis
Lead Sponsor:
Shirley Ryan AbilityLab
Collaborating Sponsors:
Edward Hines Jr. VA Hospital
Conditions:
Multiple Sclerosis, Relapsing-Remitting
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The overall objective of this project is to investigate the effectiveness of Acute Intermittent Hypoxia (AIH), to improve muscle strength and activity level in individuals with relapsing-remitting MS.
Eligibility Criteria
Inclusion
- Have relapsing-remitting MS
- Volitional ankle plantar flexion strength in at least one leg
- Are relapse free for 30 days
- Patient-Determined Disease Steps scale score between 3 and 5 (3=gait disability to 5=late cane, need cane to walk 25 feet)
Exclusion
- Currently taking antispasticity medications,
- Have cardiovascular or respiratory/pulmonary disorders, metabolic dysfunction, or prior diagnoses of obstructive sleep apnea
- Pregnant or nursing women (safety for developing fetus or infant is unknown)
- Cognitive concerns (must be able to consent to study, follow steps)
Key Trial Info
Start Date :
June 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04280484
Start Date
June 18 2018
End Date
December 30 2019
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shirley Ryan AbilityLab
Chicago, Illinois, United States, 60611